InsidersTradesSigma
Follow the Evolent Health, Inc. stock price and the full management transaction log of the company, a listed equity based in United States. Shares are listed on the US market, under the authority of SEC (Form 4). Operating in the Healthcare & Pharma sector, Evolent Health, Inc. has published 188 public disclosures. Market capitalisation: €556.3m. The latest transaction was reported on 28 August 2026 (Cession). Among the most active insiders: WILLIAMS FRANK J. All data is accessible without an account.
188
Insider Decl.
n/a
Thresholds
€1m
10 ops.
Buy Volume
€5m
19 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Evolent Health, Inc. Buy (bullish), based on 13 analysts. Average price target: US$5.77.
33Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 27,140 of 29,062 companies
18.0
score / 100
Value23
Quality13
FCF yld0.9%
Earn yld-111%
EV/EBITDA·
ROE-67%
Gross mgn21%
Net mgn-31%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 28 August 2026
Declarations188 total
65,892 shares@ US$5.00Class A Common StockSEC:0001628908-26-000088:0
65,892 shares@ US$4.96990.059% mcap100.0% of flowCommonSEC144:0001628280-26-059130
10,297 shares@ US$5.740.0093% mcap1.7% of flowClass A Common StockSEC:0001628908-26-000070:1
446,102 shares0Class A Common StockSEC:0001628908-26-000070:0
4,582 shares@ US$5.740.0041% mcap4.7% of flowClass A Common StockSEC:0001628908-26-000068:1
2,650 shares@ US$5.740.0024% mcap1.5% of flowClass A Common StockSEC:0001642833-26-000004:1
302,585 shares0Class A Common StockSEC:0001628908-26-000068:0
28,790 shares0Class A Common StockSEC:0001628908-26-000066:0
43,055 shares0Class A Common StockSEC:0001642833-26-000004:0
41,096 shares0Class A Common StockSEC:0001628908-26-000041:0
41,096 shares0Class A Common StockSEC:0001628908-26-000043:0
41,096 shares0Class A Common StockSEC:0001628908-26-000053:0
41,096 shares0Class A Common StockSEC:0001628908-26-000055:0
41,096 shares0Class A Common StockSEC:0001628908-26-000057:0
41,096 shares0Class A Common StockSEC:0001628908-26-000039:0
41,096 shares0Class A Common StockSEC:0001628908-26-000049:0
41,096 shares0Class A Common StockSEC:0001628908-26-000051:0
9,537 shares@ US$3.251.0% of flowClass A Common StockSEC:0001628908-26-000023:0
7,811 shares@ US$3.254.2% of flowClass A Common StockSEC:0001628908-26-000021:0
2,577 shares@ US$3.253.7% of flowClass A Common StockSEC:0001628908-26-000019:0
4,406 shares@ US$3.251.6% of flowClass A Common StockSEC:0001642833-26-000002:0
23,137 shares0Class A Common StockSEC:0001628908-26-000006:0
587,500 shares0Class A Common StockSEC:0001628908-26-000004:0
10,000 shares@ US$3.819920.4% of flowClass A Common StockSEC:0001628908-25-000138:0
Canonical exit: 16 Feb 2026 (T+90)
25 of 188 declarations
关于 Evolent Health, Inc.
Evolent Health, Inc. (NYSE: EVH) 是一家在美国上市的医疗保健公司，总部位于弗吉尼亚州阿灵顿。该公司由包括 Seth Blackley 在内的医疗保健高管于 2010 年代初创立，其平台旨在改善复杂疾病患者的临床结果，并降低护理成本和管理复杂性。从最初的基于价值的护理平台，Evolent 通过有机增长和收购的结合，发展成为一家更专注于专业护理管理业务的公司，为美国各地的国家级支付方和医疗服务提供商组织提供服务。([evolent.com](https://www.evolent.com/about-us)) Evolent 的核心定位在于专业疾病管理和医疗保健简化。其解决方案涵盖以绩效为导向的护理管理、专业技术和服务以及行政服务。实际上，这意味着该公司帮助健康计划和提供商管理高成本、高变异性的领域，例如肿瘤学、心脏病学、肌肉骨骼护理、手术管理和高级影像。其模式结合了临床专业知识、数据驱动的工作流程、自动化和支付方-提供商协作，以改善结果，同时减少可避免的利用率和行政负担。([evolent.com](https://www.evolent.com/about-us)) 从竞争角度来看，Evolent 并非试图成为一家广泛多元化的健康保险公司或通用的服务供应商。相反，它作为一家拥有深厚临床能力和专注于复杂疾病的产品堆栈的专家进行竞争。这种专业化在医疗成本不断上升以及提高质量的压力促使支付方寻求外部专业知识的市场中至关重要。管理层一再强调强劲的销售环境、其可寻址类别中较低的市场渗透率，以及通过地理、业务线或服务范围扩大现有关系的能力。([ir.evolent.com](https://ir.evolent.com/2025-05-08-Evolent-Announces-First-Quarter-2025-Results)) 公司的增长历史受到旨在扩大其专业足迹的收购的影响。值得注意的交易包括 New Century Health、IPG 和 Vital Decisions，这些交易扩大了 Evolent 在专业护理、手术管理和高级护理规划方面的能力。最近，Evolent 宣布剥离其基于价值的初级护理业务 Evolent Care Partners，以进一步专注于专业疾病管理并加速去杠杆化。此举标志着更严格的投资组合策略和对现金生成和资产负债表改善的更明确强调。([ir.evolent.com](https://ir.evolent.com/2018-10-02-Evolent-Health-Completes-Acquisition-of-New-Century-Health?utm_source=openai)) 在地理上，Evolent 主要在美国运营，服务于全国客户群，而非集中在单一区域。最近的披露显示，其部署涵盖多个业务线，包括 Medicare Advantage、Medicaid 和商业计划，并在美国多个市场取得了新的成功和扩张。2025 年初，该公司报告了五项新的收入协议，并重申了全年指导，同时还强调了其不断增长的业务管道、AI 驱动的自动化计划以及对盈利能力和债务偿还的持续关注。对于投资者而言，EVH 是一家在美国上市的医疗保健服务公司，具有专业的增长概况、显著的执行杠杆以及对需求顺风和报销/监管复杂性的敞口。([ir.evolent.com](https://ir.evolent.com/2025-05-08-Evolent-Announces-First-Quarter-2025-Results))
